Lupin informs about press release

20 May 2025 Evaluate
Lupin has informed that it enclosed a Press Release as regards, use of Honeywell’s Solstice Air (HFO-1234ze cGMP) propellant by the Company, to transform respiratory care through the development of next-generation inhalers.

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2137.15 -27.90 (-1.29%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×